JP2023509973A5 - - Google Patents

Info

Publication number
JP2023509973A5
JP2023509973A5 JP2022542247A JP2022542247A JP2023509973A5 JP 2023509973 A5 JP2023509973 A5 JP 2023509973A5 JP 2022542247 A JP2022542247 A JP 2022542247A JP 2022542247 A JP2022542247 A JP 2022542247A JP 2023509973 A5 JP2023509973 A5 JP 2023509973A5
Authority
JP
Japan
Prior art keywords
sequence
antibody
cancer
antigen
sequence shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022542247A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023509973A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NL2021/050009 external-priority patent/WO2021141492A1/en
Publication of JP2023509973A publication Critical patent/JP2023509973A/ja
Publication of JP2023509973A5 publication Critical patent/JP2023509973A5/ja
Priority to JP2026006029A priority Critical patent/JP2026086455A/ja
Pending legal-status Critical Current

Links

JP2022542247A 2020-01-10 2021-01-08 上皮カドヘリン特異性抗体 Pending JP2023509973A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026006029A JP2026086455A (ja) 2020-01-10 2026-01-16 上皮カドヘリン特異性抗体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20151325 2020-01-10
EP20151325.6 2020-01-10
PCT/NL2021/050009 WO2021141492A1 (en) 2020-01-10 2021-01-08 Epithelial cadherin-specific antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026006029A Division JP2026086455A (ja) 2020-01-10 2026-01-16 上皮カドヘリン特異性抗体

Publications (2)

Publication Number Publication Date
JP2023509973A JP2023509973A (ja) 2023-03-10
JP2023509973A5 true JP2023509973A5 (cg-RX-API-DMAC7.html) 2024-01-17

Family

ID=69159601

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022542247A Pending JP2023509973A (ja) 2020-01-10 2021-01-08 上皮カドヘリン特異性抗体
JP2026006029A Pending JP2026086455A (ja) 2020-01-10 2026-01-16 上皮カドヘリン特異性抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026006029A Pending JP2026086455A (ja) 2020-01-10 2026-01-16 上皮カドヘリン特異性抗体

Country Status (11)

Country Link
US (1) US20240317880A1 (cg-RX-API-DMAC7.html)
EP (1) EP4087872A1 (cg-RX-API-DMAC7.html)
JP (2) JP2023509973A (cg-RX-API-DMAC7.html)
KR (1) KR20220131527A (cg-RX-API-DMAC7.html)
CN (2) CN115066439A (cg-RX-API-DMAC7.html)
AU (1) AU2021206586A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022013601A2 (cg-RX-API-DMAC7.html)
CA (1) CA3163286A1 (cg-RX-API-DMAC7.html)
IL (1) IL294342A (cg-RX-API-DMAC7.html)
MX (1) MX2022008391A (cg-RX-API-DMAC7.html)
WO (1) WO2021141492A1 (cg-RX-API-DMAC7.html)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681581A (en) 1983-12-05 1987-07-21 Coates Fredrica V Adjustable size diaper and folding method therefor
US4735210A (en) 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
US5101827A (en) 1985-07-05 1992-04-07 Immunomedics, Inc. Lymphographic and organ imaging method and kit
US5776093A (en) 1985-07-05 1998-07-07 Immunomedics, Inc. Method for imaging and treating organs and tissues
US5648471A (en) 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
CA2065299C (en) 1989-08-09 2001-07-24 Buck A. Rhodes Direct radiolabeling of antibodies and other proteins with technetium or rhenium
US8940501B2 (en) 2009-01-30 2015-01-27 Whitehead Institute For Biomedical Research Methods for ligation and uses thereof
WO2012058418A2 (en) * 2010-10-27 2012-05-03 The Research Foundation Of State University Of New York Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy
SI2634194T1 (sl) * 2010-10-29 2018-11-30 Perseus Proteomics Inc. Anti-cdh3 protitelo, ki ima visoko kapaciteto internalizacije
CN107287660A (zh) * 2011-09-30 2017-10-24 中外制药株式会社 离子浓度依赖性结合分子文库
WO2013081463A2 (en) 2011-12-02 2013-06-06 Aimm Therapeutics B.V. Influenza a virus specific antibodies
US9534058B2 (en) * 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
JP2016531915A (ja) * 2013-08-28 2016-10-13 ステムセントリックス, インコーポレイテッド 部位特異的抗体コンジュゲーション方法および組成物
EP3572425A1 (en) 2013-12-17 2019-11-27 AIMM Therapeutics B.V. Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
MX2018006072A (es) * 2015-11-19 2018-08-01 Squibb Bristol Myers Co Anticuerpos contra receptor de factor de necrosis de tumor inducido por glucocorticoides (gitr) y usos de los mismos.

Similar Documents

Publication Publication Date Title
JP7583707B2 (ja) 抗cd47抗体及びその応用
JP7461950B2 (ja) Cd3抗体およびその医薬用途
CN112969476B (zh) 多特异性蛋白分子
CN112574307A (zh) 抗人Claudin18.2抗体及其应用
JP2021514664A5 (cg-RX-API-DMAC7.html)
CA3118775A1 (en) Anti-cd73 antibody, antigen-binding fragment thereof and application thereof
CN115052896A (zh) 抗ror1抗体和组合物
JP2021528047A5 (cg-RX-API-DMAC7.html)
CN114181310A (zh) 抗tigit抗体、其药物组合物及用途
EP4393950A1 (en) Fap/cd40 binding molecule and medicinal use thereof
TWI797609B (zh) 抗pd-1和pd-l1的四價雙特異性抗體
JP2024001073A5 (cg-RX-API-DMAC7.html)
CN113683697B (zh) 抗b7-h3抗体、其制备方法及用途
CN113563473A (zh) 四价双特异性抗体、其制备方法和用途
WO2024114676A1 (zh) Cldn18.2/4-1bb结合蛋白及其医药用途
WO2023104080A1 (zh) 抗trop-2抗体或其抗原结合片段
JP2023525991A5 (cg-RX-API-DMAC7.html)
CN112805297B (zh) 抗人类pd-l1抗体及其用途
JP2025517737A5 (cg-RX-API-DMAC7.html)
US10781265B2 (en) Humanized antibodies against Globo H and uses thereof in cancer treatments
WO2025016459A1 (zh) 一种抗fgfr2/pd-1双特异性抗体
CN116813786B (zh) 抗cd73抗体及其应用
CN113754774A (zh) 一种抗pd-l1和egfr的四价双特异性抗体
WO2024131846A1 (en) Antibody, antigen-binding fragment thereof, and pharmaceutical use thereof
CN115073596B (zh) 一种人源化Claudin18.2抗体及其应用